Page 560 - ACCCN's Critical Care Nursing

Gastrointestinal, Liver and Nutritional Alterations 537

296. Renz JF, Yersiz H, Reichert PR, Hisatake GM, Farmer DG et al. Split-liver 324. Annane D, Cariou A, Maxime V, Azoulay E, D’Honneur G et al. Corticoste-
transplantation: a review. Am J Transplant 2003; 3(11): 1323–35. roid treatment and intensive insulin therapy for septic shock in adults: a
297. Crawford M, Shaked A. The liver transplant operation. Graft 2003; 6(2): randomized controlled trial. JAMA 2010; 303(4): 341–8.
98-109. 325. Louie K, Cheema R, Dodek P, Wong H, Wilmer A et al. Intensive nursing
298. Russo MW, Brown RS, Jr. Adult living donor liver transplantation. Am work schedules and the risk of hypoglycaemia in critically ill patients who
J Transplant 2004; 4(4): 458–65. are receiving intravenous insulin. Qual Saf Health Care; 2010. doi:10.1136/
299. McGilvray ID, Greig PD. Critical care of the liver transplant patient: an qshc.2009.036020
update. Curr Opin Crit Care 2002; 8(2): 178–82. 326. Petersen JR, Graves DF, Tacker DH, Okorodudu AO, Mohammad AA, Carde-
300. Saner F, Kavuk I, Lang H, Fruhauf NR, Paul A et al. Postoperative ICU man- nas VJ, Jr. Comparison of POCT and central laboratory blood glucose results
agement in liver transplant patients. Eur J Med Res 2003; 8(11): 511–16. using arterial, capillary, and venous samples from MICU patients on a tight
301. Gruppi LA, Killen AR, Rodriguez W. Liver transplantation: key nursing diag- glycemic protocol. Clin Chim Acta 2008; 396(1–2): 10–13.
noses. Dimen Crit Care Nurs 1990; 9(5): 272–9. 327. Slater-MacLean L, Cembrowski G, Chin D, Shalapay C, Binette T et al. Accu-
302. Larsen FS, Strauss G, Knudsen GM, Herzog TM, Hansen BA, Secher NH. racy of glycemic measurements in the critically ill. Diabetes Technol Ther 2008;
Cerebral perfusion, cardiac output, and arterial pressure in patients with 10(3): 169–77.
fulminant hepatic failure. Crit Care Med 2000; 28(4): 996–1000. 328. Desachy A, Vuagnat AC, Ghazali AD, Baudin OT, Longuet OH et al. Accuracy
303. Bronster DJ, Emre S, Boccagni P, Sheiner PA, Schwartz ME, Miller CM. of bedside glucometry in critically ill patients: influence of clinical charac-
Central nervous system complications in liver transplant recipients – inci- teristics and perfusion index. Mayo Clin Proc 2008; 83(4): 400–405.
dence, timing, and long-term follow-up. Clin Transplant 2000; 14(1): 329. Critchell CD, Savarese V, Callahan A, Aboud C, Jabbour S, Marik P. Accuracy
1–7. of bedside capillary blood glucose measurements in critically ill patients.
304. Donaghy A. Issues of malnutrition and bone disease in patients with cir- Intensive Care Med 2007; 33(12): 2079–84.
rhosis. J Gastroenterol Hepatol 2002; 17(4): 462–6. 330. Wahl HG. How accurately do we measure blood glucose levels in intensive
305. Lynn M, Abreo K, Zibari G, McDonald J. End-stage renal disease in liver care unit (ICU) patients? Best Pract Res Clin Anaesthesiol 2009; 23(4): 387–400.
transplants. Clin Transplant 2001; 15(Suppl 6): 66–9. 331. Vesper HW, Archibold E, Myers GL. Assessment of trueness of glucose mea-
306. Tippner C, Nashan B, Hoshino K, Schmidt-Sandte E, Akimaru K et al. Clini- surement instruments with different specimen matrices. Clin Chim Acta
cal and subclinical acute rejection early after liver transplantation: contribut- 2005; 358(1–2): 68–74.
ing factors and relevance for the long-term course. Transplantation 2001; 332. Mahoney J, Ellison J. Assessing the quality of glucose monitor studies: a
72(6): 1122–8. critical evaluation of published reports. Clin Chem 2007; 53(6): 1122–8.
307. Cohen SM. Current immunosuppression in liver transplantation. Am J Ther 333. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP et al. The
2002; 9(2): 119–25. STARD statement for reporting studies of diagnostic accuracy: explanation
308. Lucey MR, Neuberger J, Shaked A. Liver transplantation. Washington: Landes and elaboration. The Standards for Reporting of Diagnostic Accuracy Group.
Bioscience; 2003. Croat Med J 2003; 44(5): 639–50.
309. Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA et al. Use of OKT3 334. National Committee for Clinical Laboratory Standards (NCCLS). Point-of-
is associated with early and severe recurrence of hepatitis C after liver trans- care blood glucose testing in acute and chronic care facilities; approved guideline
plantation. Am J Gastroenterol 1997; 92(9): 1453–7. 2nd edn. Wayne, PA: NCCLS; 2002.
310. Levy MF, Greene L, Ramsay MA, Jennings LW, Ramsay KJ et al. Readmission 335. Van den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A et al.
to the intensive care unit after liver transplantation. Crit Care Med 2001; Clinical review: Intensive insulin therapy in critically ill patients: NICE-
29(1): 18–24. SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab 2009; 94(9):
311. Bilbao I, Armadans L, Lazaro JL, Hidalgo E, Castells L, Margarit C. Predictive 3163–70.
factors for early mortality following liver transplantation. Clin Transplant 336. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM et al. Surviving Sepsis
2003; 17(5): 401–11. Campaign: international guidelines for management of severe sepsis and
312. Van Cromphaut SJ. Hyperglycaemia as part of the stress response: the under- septic shock: 2008. Crit Care Med 2008; 36(1): 296–327.
lying mechanisms. Best Pract Res Clin Anaesthesiol 2009; 23(4): 375–86. 337. Australian Institute of Health and Welfare (AIHW). Diabetes prevalance in
313. Robinson LE, van Soeren MH. Insulin resistance and hyperglycemia in criti- Australia: an assessment of national data sources. Canberra: AIHW; 2009.
cal illness: role of insulin in glycemic control. AACN Clin Issues 2004; 15(1): 338. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes:
45–62. estimates for the year 2000 and projections for 2030. Diabetes Care 2004;
314. Finfer S, Chittock DR, Su SY, Blair D, Foster D et al. Intensive versus conven- 27(5): 1047–53.
tional glucose control in critically ill patients. N Engl J Med 2009; 360(13): 339. Colagiur IS, Borch-Johnsen K, Glumer C, Vistisen D. Is there really an epi-
1283–97. demic of type 2 diabetes? Diabetologia 2005; 48: 1459–63.
315. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA et al. 340. Tobias M, Cheung J. Diabetes in New Zealand, models and forecasts 1996–2011.
Intensive versus conventional insulin therapy: a randomized controlled trial Wellington, New Zealand: New Zealand Ministry of Health; 2002 [cited June
in medical and surgical critically ill patients. Crit Care Med 2008; 36(12): 2005]. Available from: http://www.moh.govt.nz/moh.nsf/7004be0c19a98f
3190–97. 8a4c25692e007bf833/16a3945b4714f9fccc256b74000f3551?
316. De La Rosa Gdel C, Donado JH, Restrepo AH, Quintero AM, Gonzalez LG OpenDocument.
et al. Strict glycaemic control in patients hospitalised in a mixed medical 341. Brenner ZR. Management of hyperglycemic emergencies. AACN Clin Issues
and surgical intensive care unit: a randomised clinical trial. Crit Care 2008; 2006; 17(1): 56–65; quiz 91–3.
12(5): R120. 342. Yared Z, Chiasson JL. Ketoacidosis and the hyperosmolar hyperglycemic state
317. Devos P, Preiser JC. Impact of tight glucose control by intensive insulin in adult diabetic patients. Diagnosis and treatment. Minerva Med 2003;
therapy on ICU mortality and the rate of hypoglycaemia: final results of the 94(6): 409–18.
Glucontrol study. Intens Care Med 2007; 33(Supp2): S189. 343. Newton CA, Raskin P. Diabetic ketoacidosis in type 1 and type 2 diabetes
318. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independant mellitus: clinical and biochemical differences. Arch Intern Med 2004;
predictor of poor outcome after acute stroke? Results of a long term follow 164(17):1925–31.
up study. BMJ 1997; 314: 1303–6. 344. Schmitz K. Providing the best possible care: an overview of the current
319. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and understanding of diabetic ketoacidosis. Aust Crit Care 2000; 13(1): 22–7.
increased risk of death after myocardial infarction in patients with and 345. Bardsley JK, Want LL. Overview of diabetes. Crit Care Nurs Q 2004; 27(2):
without diabetes: a systematic review. Lancet 2000; 355(9206): 773–8. 106–12.
320. Van den Berghe G, Wouters P, Bouilon R, Weekers F, Verwaest C et al. 346. Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Sicree RA et al.
Outcome benefit of intensive insulin therapy in the critically ill: insulin dose The rising prevalence of diabetes and impaired glucose tolerance: The Aus-
versus glycemic control. Crit Care Med 2003; 31(2): 359–66. tralian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25(2):
321. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ et al. Inten- 829–34.
sive insulin therapy and mortality among critically ill patients: a meta- 347. Boyle M, Lawrence J. An easy method of mentally estimating the metabolic
analysis including NICE-SUGAR study data. CMAJ 2009; 180(8): 821–7. component of acid/base balance using the Fencl-Stewart approach. Anaesth
322. Padkin A. How to weigh the current evidence for clinical practice. Best Pract Intensive Care 2003; 31(5): 538–47.
Res Clin Anaesthesiol 2009; 23(4): 487–96. 348. Hardern RD, Quinn ND. Emergency management of diabetic ketoacidosis
323. Mesotten D, Van den Berghe G. Clinical benefits of tight glycaemic control: in adults. Emerg Med J 2003; 20(3): 210–13.
focus on the intensive care unit. Best Pract Res Clin Anaesthesiol 2009; 23(4): 349. Kitabachi AE, Wall BM. Diabetic ketoacidosis. Med Clin North Am 1995;
421–9. 79(1): 9–37.